What are the diagnostic criteria for pre-eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Pre-eclampsia

Pre-eclampsia is defined as gestational hypertension (≥140/90 mmHg) that appears after 20 weeks of gestation, accompanied by one or more of the following: proteinuria, maternal organ dysfunction, or uteroplacental dysfunction. 1

Primary Diagnostic Criteria

  • Blood pressure ≥140/90 mmHg on two separate occasions at least 4 hours apart (or within 15 minutes apart in cases of severe hypertension ≥160/110 mmHg) 1, 2
  • Onset after 20 weeks of gestation in a previously normotensive woman 1, 3
  • Accompanied by at least one of the following:

Proteinuria

  • ≥0.3 g/24h in 24-hour urine collection 1, 2
  • Protein/creatinine ratio ≥30 mg/mmol 1, 4
  • Albumin/creatinine ratio ≥30 mg/mmol 1
  • Positive dipstick test (≥1+) should prompt quantitative assessment 1

Maternal Organ Dysfunction (in absence of proteinuria)

  • Renal: Serum creatinine ≥1.1 mg/dL or doubling of baseline 5, 1
  • Hepatic: Elevated liver transaminases (≥2 times upper limit of normal) 5, 1
  • Neurological: Severe headache, visual disturbances, eclampsia 1
  • Hematological: Thrombocytopenia (<100,000/microliter) 5
  • Pulmonary: Pulmonary edema 1

Uteroplacental Dysfunction

  • Fetal growth restriction 1
  • Abnormal umbilical artery Doppler waveform 1
  • Intrauterine fetal death 1

Important Clinical Considerations

  • The 20-week threshold is pathophysiologically significant as it reflects when placental development and remodeling of maternal spiral arteries should be complete 3
  • Hypertension appearing before 20 weeks typically represents pre-existing or chronic hypertension, not preeclampsia 3
  • Proteinuria is present in approximately 75% of preeclampsia cases but is not required for diagnosis 5
  • The sFlt-1/PlGF ratio ≤38 can help exclude the development of preeclampsia in the following week when clinically suspected 1

Monitoring and Assessment

  • All women with suspected preeclampsia should have:

    • Full blood count (hemoglobin and platelet count) 5
    • Liver enzymes (AST, ALT, LDH) and function tests (INR, bilirubin, albumin) 5
    • Serum creatinine, electrolytes, and uric acid 5
    • Urinalysis and protein quantification 5
  • Blood pressure monitoring should be performed regularly, with values consistently ≥140/90 mmHg requiring treatment 5

  • Urgent treatment in a monitored setting is required when BP ≥160/110 mmHg 5

Classification of Severity

  • There should be no attempt to diagnose mild versus severe preeclampsia clinically as all cases may become emergencies, often rapidly 5
  • Preeclampsia with severe features includes:
    • Severe hypertension (≥160/110 mmHg) despite treatment with multiple antihypertensives 5
    • Progressive thrombocytopenia 5
    • Progressive abnormal renal or liver enzyme tests 5
    • Pulmonary edema 5
    • Neurological complications 5
    • Non-reassuring fetal status 5

Differential Diagnosis

  • Gestational hypertension (hypertension without proteinuria or other features) 1
  • Chronic hypertension (pre-existing or appearing before 20 weeks) 1
  • Preeclampsia superimposed on chronic hypertension 1

Common Pitfalls

  • Neither serum uric acid nor the level of proteinuria should be used as an indication for delivery 5
  • Repeated measurement of proteinuria is not recommended for monitoring disease progression, as the amount of proteinuria does not correlate well with maternal and neonatal outcomes 6
  • Hyper-reflexia is a nonspecific finding often present in otherwise healthy young women and is no longer recommended as a diagnostic criterion 5
  • In women with chronic kidney disease, baseline protein excretion evaluation is critical for later comparison 6

References

Guideline

Preeclampsia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intensive Care Unit issues in eclampsia and HELLP syndrome.

International journal of critical illness and injury science, 2017

Guideline

Preeclampsia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Albumin/Creatinine Ratio for the Detection of Significant Proteinuria of Preeclampsia in Hospitalized Hypertensive Women.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.